Global Clinical Trial Imaging Market Size study & Forecast, by Product and Service, by Modality, by End-User and Regional Analysis, 2023-2030

Description

List of Tables

Global Clinical Trial Imaging Market is valued at approximately USD 1.13 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.38% during the forecast period 2023-2030. Clinical Trial Imaging refers to the use of various imaging techniques and technologies to assess and monitor the effects of a medical intervention, such as a new drug or medical device, during a clinical trial. These trials are conducted to evaluate the safety and efficacy of the intervention in human subjects. The Clinical Trial Imaging Market is expanding because of factors such as the increasing number of clinical trials and the growing number of Contract Research Organizations (CROs). Imaging plays a crucial role in clinical trials by providing detailed visual information about the anatomy, physiology, and function of the human body. As a result, the demand for Clinical Trial Imaging has progressively increased in the international market during the forecast period 2023-2030.

Regulatory bodies play a crucial role in approving new medical interventions, and imaging data often contribute to these decisions. The increasing number of trials could lead to more extensive regulatory scrutiny, emphasizing the importance of adhering to guidelines for imaging data acquisition, analysis, and reporting. According to Statista, the number of registered clinical studies in non-U.S. areas was approximately 242 thousand, whereas the number in the United States was more than 141 thousand. Another important factor that drives the Clinical Trial Imaging Market is the increasing number of Contract Research Organizations (CROs) that can facilitate the efficient start-up of clinical trials by streamlining the process of selecting imaging sites, implementing standardized imaging protocols, and ensuring compliance with regulatory requirements. This efficiency can positively impact the overall timeline of the clinical trial. In addition, as per Statista, in 2023, the anticipated global market size for Contract Research Organizations (CROs) accounts for approximately USD 77 billion worldwide and is projected to reach up to USD 127.3 billion by the year 2028. Moreover, the surge in R&D expenditure in pharmaceutical and biotechnological companies and rising healthcare expenditure across the world are anticipated to create lucrative growth opportunities for the market over the forecast period. However, high-risk Radiation Causing Diseases and stringent regulatory policies are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Trial Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of major outsourcing companies such as Charles River Laboratories International, Inc., IQVIA Inc., and so on along with the increasing number of research and development activities in the region. R&D initiatives lead to a better understanding of disease mechanisms and treatment effects. This knowledge allows for the development of customized imaging protocols tailored to specific therapeutic areas, optimizing the relevance and efficiency of clinical trial imaging. The region's dominant performance is anticipated to propel the overall demand for Clinical Trial Imaging. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as rapid growth of the population, and increased research and development activities in the region.

Major market player included in this report are:

IXICO plc
Navitas Life Sciences
Resonance Health Ltd
ProScan Imaging
Radiant Sage LLC
Medpace Holdings, Inc.
Biomedical Systems Corp
Cardiovascular Imaging Technologies
Intrinsic Imaging LLC
BioTelemetry Inc

Recent Developments in the Market:

In September 2023, Mayo Clinic and GE HealthCare unveiled a strategic alliance in healthcare, focusing on collaborative research and product development initiatives. This partnership is designed to revolutionize the interactions between patients and healthcare professionals within radiology practices and the administration of innovative therapies. Named the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, this initiative brings together a team of experts from Mayo Clinic and GE HealthCare, including scientists, technology developers, clinicians, and other healthcare providers. The primary objective of this collaboration is to empower clinicians with advanced technology for precise diagnosis and treatment of medical conditions. Additionally, the partnership aims to enhance the patient experience by integrating novel technologies and approaches to medical imaging and theranostics, thereby personalizing each phase of the patient's care journey.

Global Clinical Trial Imaging Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product and Service, Modality, End-User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Service

Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software

By Modality

Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities

By End-User

Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Academic and Government Research Institutes

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Clinical Trial Imaging Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Clinical Trial Imaging Market, by Product and Service, 2020-2030 (USD Billion)
- 1.2.3. Clinical Trial Imaging Market, by Modality, 2020-2030 (USD Billion)
- 1.2.4. Clinical Trial Imaging Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Clinical Trial Imaging Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Clinical Trial Imaging Market Dynamics

3.1. Clinical Trial Imaging Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing number of clinical trials
  - 3.1.1.2. Growing number of Contract Research Organizations (CROs)
- 3.1.2. Market Challenges
  - 3.1.2.1. High-Risk Radiation Causing Diseases
  - 3.1.2.2. Stringent Regulatory Policies
- 3.1.3. Market Opportunities
  - 3.1.3.1. Surge in R&D expenditure in pharmaceutical and biotechnological companies
  - 3.1.3.2. Rise in Healthcare Expenditure across the world

Chapter 4. Global Clinical Trial Imaging Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Trial Imaging Market, by Product and Service

5.1. Market Snapshot
5.2. Global Clinical Trial Imaging Market by Product and Service, Performance - Potential Analysis
5.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Product and Service 2020-2030 (USD Billion)
5.4. Clinical Trial Imaging Market, Sub Segment Analysis
- 5.4.1. Trial Design Consulting Services
- 5.4.2. Read Analysis Services
- 5.4.3. Operational Imaging Services
- 5.4.4. Imaging Software

Chapter 6. Global Clinical Trial Imaging Market, by Modality

6.1. Market Snapshot
6.2. Global Clinical Trial Imaging Market by Modality, Performance - Potential Analysis
6.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
6.4. Clinical Trial Imaging Market, Sub Segment Analysis
- 6.4.1. Magnetic Resonance Imaging
- 6.4.2. Computed Tomography
- 6.4.3. Ultrasound
- 6.4.4. Positron Emission Tomography
- 6.4.5. X-Ray
- 6.4.6. Echocardiography
- 6.4.7. Other Modalities

Chapter 7. Global Clinical Trial Imaging Market, by End-User

7.1. Market Snapshot
7.2. Global Clinical Trial Imaging Market by End-User, Performance - Potential Analysis
7.3. Global Clinical Trial Imaging Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Clinical Trial Imaging Market, Sub Segment Analysis
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. Medical Device Manufacturers
- 7.4.3. Academic and Government Research Institutes

Chapter 8. Global Clinical Trial Imaging Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Clinical Trial Imaging Market, Regional Market Snapshot
8.4. North America Clinical Trial Imaging Market
- 8.4.1. U.S. Clinical Trial Imaging Market
  - 8.4.1.1. Product and Service breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Clinical Trial Imaging Market
8.5. Europe Clinical Trial Imaging Market Snapshot
- 8.5.1. U.K. Clinical Trial Imaging Market
- 8.5.2. Germany Clinical Trial Imaging Market
- 8.5.3. France Clinical Trial Imaging Market
- 8.5.4. Spain Clinical Trial Imaging Market
- 8.5.5. Italy Clinical Trial Imaging Market
- 8.5.6. Rest of Europe Clinical Trial Imaging Market
8.6. Asia-Pacific Clinical Trial Imaging Market Snapshot
- 8.6.1. China Clinical Trial Imaging Market
- 8.6.2. India Clinical Trial Imaging Market
- 8.6.3. Japan Clinical Trial Imaging Market
- 8.6.4. Australia Clinical Trial Imaging Market
- 8.6.5. South Korea Clinical Trial Imaging Market
- 8.6.6. Rest of Asia Pacific Clinical Trial Imaging Market
8.7. Latin America Clinical Trial Imaging Market Snapshot
- 8.7.1. Brazil Clinical Trial Imaging Market
- 8.7.2. Mexico Clinical Trial Imaging Market
8.8. Middle East & Africa Clinical Trial Imaging Market
- 8.8.1. Saudi Arabia Clinical Trial Imaging Market
- 8.8.2. South Africa Clinical Trial Imaging Market
- 8.8.3. Rest of Middle East & Africa Clinical Trial Imaging Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. IXICO plc
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Navitas Life Sciences
- 9.3.3. Resonance Health Ltd
- 9.3.4. ProScan Imaging
- 9.3.5. Radiant Sage LLC
- 9.3.6. Medpace Holdings, Inc
- 9.3.7. Biomedical Systems Corp
- 9.3.8. Cardiovascular Imaging Technologies
- 9.3.9. Intrinsic Imaging LLC
- 9.3.10. BioTelemetry, Inc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Clinical Trial Imaging Market, report scope
TABLE 2. Global Clinical Trial Imaging Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Clinical Trial Imaging Market estimates & forecasts by Product and Service 2020-2030 (USD Billion)
TABLE 4. Global Clinical Trial Imaging Market estimates & forecasts by Modality 2020-2030 (USD Billion)
TABLE 5. Global Clinical Trial Imaging Market estimates & forecasts by End-User 2020-2030 (USD Billion)
TABLE 6. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Clinical Trial Imaging Market
TABLE 71. List of primary sources, used in the study of global Clinical Trial Imaging Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Clinical Trial Imaging Market, research methodology
FIG 2. Global Clinical Trial Imaging Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Clinical Trial Imaging Market, key trends 2022
FIG 5. Global Clinical Trial Imaging Market, growth prospects 2023-2030
FIG 6. Global Clinical Trial Imaging Market, porters 5 force model
FIG 7. Global Clinical Trial Imaging Market, pest analysis
FIG 8. Global Clinical Trial Imaging Market, value chain analysis
FIG 9. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Clinical Trial Imaging Market, regional snapshot 2020 & 2030
FIG 15. North America Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
FIG 16. Europe Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Clinical Trial Imaging Market 2020 & 2030 (USD Billion)